BioSpace News Archive

ExplORer Surgical, a leading platform for intraoperative surgical and interventional procedure workflow management and analytics, announced today the closing of a new $5M financing round.

Through increased efforts to better manage opioid use, and encourage more appropriate therapies generally, myMatrixx helped workers’ compensation plans reduce drug spending by 3.8% in 2018, according to the annual myMatrixx Drug Trend Report released today.

PPG (NYSE:PPG) today announced at its annual meeting of shareholders that Cathy R. Smith, executive vice president and chief financial officer, Target Corporation, and Steven A. Davis, former chairman and chief executive officer, Bob Evans Farms, Inc., have been elected to join its board of directors, effective immediately.

PDI, a leader in infection prevention products and solutions for its customers, today announces three key leadership appointments to drive the company’s strategic growth and innovation initiatives and execute against its ongoing mission to provide exemplary service.

In order for doctors to communicate and access the best care, they are often forced to break the law

EY announced that Jose Vargas, co-founder & president of HealthCare.com is a finalist for the Entrepreneur Of The Year® 2019 Award in Florida.

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the first quarter ended March 31, 2019, after the market closes on Monday, May 6, 2019.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2019 financial results will be released on Thursday, May 2, after the market closes.

Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced that the U.S. Food and Drug Administration (“FDA”) has approved abbreviated new drug application (“ANDA”) No. 208024 for Fluticasone Propionate Nasal Spray USP,

Torchmark Corporation is a holding company specializing in life and supplemental health insurance for “middle income” Americans marketed through multiple distribution channels including direct response, and exclusive and independent agencies.